These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
242 related articles for article (PubMed ID: 34647424)
1. A novel m6A-related prognostic signature for predicting the overall survival of hepatocellular carcinoma patients. Xie S; Wang Y; Huang J; Li G IET Syst Biol; 2022 Feb; 16(1):1-17. PubMed ID: 34647424 [TBL] [Abstract][Full Text] [Related]
2. Exploration and validation of a combined Hypoxia and m6A/m5C/m1A regulated gene signature for prognosis prediction of liver cancer. Ren M; Fan B; Cao G; Zong R; Feng L; Sun H BMC Genomics; 2023 Dec; 24(1):776. PubMed ID: 38097948 [TBL] [Abstract][Full Text] [Related]
3. Multiomics profile and prognostic gene signature of m6A regulators in uterine corpus endometrial carcinoma. Wang Y; Ren F; Song Z; Wang X; Ma X J Cancer; 2020; 11(21):6390-6401. PubMed ID: 33033522 [TBL] [Abstract][Full Text] [Related]
4. Contributions and Prognostic Values of N6-Methyladenosine RNA Methylation Regulators in Hepatocellular Carcinoma. Qi LW; Jia JH; Jiang CH; Hu JM Front Genet; 2020; 11():614566. PubMed ID: 33519919 [TBL] [Abstract][Full Text] [Related]
5. Prognostic Value of an m6A RNA Methylation Regulator-Based Signature in Patients with Hepatocellular Carcinoma. Wu X; Zhang X; Tao L; Dai X; Chen P Biomed Res Int; 2020; 2020():2053902. PubMed ID: 32733931 [TBL] [Abstract][Full Text] [Related]
6. Cuproptosis-Related Signature Predicts the Prognosis, Tumor Microenvironment, and Drug Sensitivity of Hepatocellular Carcinoma. Qi X; Guo J; Chen G; Fang C; Hu L; Li J; Zhang C J Immunol Res; 2022; 2022():3393027. PubMed ID: 36438201 [TBL] [Abstract][Full Text] [Related]
7. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma. Guo W; Tan F; Huai Q; Wang Z; Shao F; Zhang G; Yang Z; Li R; Xue Q; Gao S; He J Front Immunol; 2021; 12():669750. PubMed ID: 34054840 [TBL] [Abstract][Full Text] [Related]
8. Identification of an m6A-Related Signature as Biomarker for Hepatocellular Carcinoma Prognosis and Correlates with Sorafenib and Anti-PD-1 Immunotherapy Treatment Response. Jiang H; Ning G; Wang Y; Lv W Dis Markers; 2021; 2021():5576683. PubMed ID: 34221187 [TBL] [Abstract][Full Text] [Related]
9. Identification of an eight-m6A RNA methylation regulator prognostic signature of uterine corpus endometrial carcinoma based on bioinformatics analysis. Miao C; Fang X; Chen Y; Zhao Y; Guo Q Medicine (Baltimore); 2021 Dec; 100(49):e27689. PubMed ID: 34889221 [TBL] [Abstract][Full Text] [Related]
10. Identification of m6A methyltransferase-related lncRNA signature for predicting immunotherapy and prognosis in patients with hepatocellular carcinoma. Li L; Xie R; Lu G Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 34027555 [TBL] [Abstract][Full Text] [Related]
11. Systematic Analyses of the Role of the Reader Protein of Shao XY; Dong J; Zhang H; Wu YS; Zheng L Front Mol Biosci; 2020; 7():577460. PubMed ID: 33344502 [TBL] [Abstract][Full Text] [Related]
12. Identification of three m6A-related mRNAs signature and risk score for the prognostication of hepatocellular carcinoma. Li Z; Li F; Peng Y; Fang J; Zhou J Cancer Med; 2020 Mar; 9(5):1877-1889. PubMed ID: 31943856 [TBL] [Abstract][Full Text] [Related]
13. A novel prognostic signature based on four glycolysis-related genes predicts survival and clinical risk of hepatocellular carcinoma. Chen Z; Zou Y; Zhang Y; Chen Z; Wu F; Shi N; Jin H J Clin Lab Anal; 2021 Nov; 35(11):e24005. PubMed ID: 34523732 [TBL] [Abstract][Full Text] [Related]
14. Analysis of m6A RNA Methylation-Related Genes in Liver Hepatocellular Carcinoma and Their Correlation with Survival. Li Y; Qi D; Zhu B; Ye X Int J Mol Sci; 2021 Feb; 22(3):. PubMed ID: 33540684 [TBL] [Abstract][Full Text] [Related]
15. Development and validation of multi-omic prognostic signature of anoikis-related genes in liver hepatocellular carcinoma. Ding D; Wang D; Qin Y Medicine (Baltimore); 2023 Nov; 102(46):e36190. PubMed ID: 37986299 [TBL] [Abstract][Full Text] [Related]
16. A signature based on neutrophil extracellular trap-related genes for the assessment of prognosis, immunoinfiltration, mutation and therapeutic response in hepatocellular carcinoma. Wang L; Wang Q; Li Y; Qi X; Fan X J Gene Med; 2024 Jan; 26(1):e3588. PubMed ID: 37715643 [TBL] [Abstract][Full Text] [Related]
17. Development and Validation of an m6A RNA Methylation Regulators-Based Signature for Predicting the Prognosis of Adrenocortical Carcinoma. Shen C; Liu J; Yang X; Jiao W; Wang Y Front Endocrinol (Lausanne); 2021; 12():568397. PubMed ID: 33692753 [TBL] [Abstract][Full Text] [Related]
18. Constructing and validating of m7G-related genes prognostic signature for hepatocellular carcinoma and immune infiltration: potential biomarkers for predicting the overall survival. Liu P; Dong C; Shi H; Yan Z; Zhang J; Liu J J Gastrointest Oncol; 2022 Dec; 13(6):3169-3182. PubMed ID: 36636051 [TBL] [Abstract][Full Text] [Related]
19. Construction and Validation of a Prognostic Gene-Based Model for Overall Survival Prediction in Hepatocellular Carcinoma Using an Integrated Statistical and Bioinformatic Approach. Dessie EY; Tu SJ; Chiang HS; Tsai JJP; Chang YS; Chang JG; Ng KL Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562824 [TBL] [Abstract][Full Text] [Related]
20. Integrative analysis identifies key mRNA biomarkers for diagnosis, prognosis, and therapeutic targets of HCV-associated hepatocellular carcinoma. Zhang Y; Tang Y; Guo C; Li G Aging (Albany NY); 2021 May; 13(9):12865-12895. PubMed ID: 33946043 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]